Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice

Neuroscience Letters

Volumn 512, Issue 1, 2012, Pages 1-5

  Murphy Nakhnikian, Alexander ^a   Dorner, Jenelle L ^a   Fischer, Benjamin I ^a   Bower Bir, Nathan D ^a   Rebec, George V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Basal ganglia; Huntington's disease; Knock in mice; Spike burst; Substantia nigra reticulata

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUNTINGTON CHOREA; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE CONDUCTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SINGLE NEURON ACTIVITY; SPIKE; SUBSTANTIA NIGRA PARS RETICULATA;

ACTION POTENTIALS; ANIMALS; GENE KNOCK-IN TECHNIQUES; HUNTINGTON DISEASE; MICE; NEURONS; SUBSTANTIA NIGRA; TRINUCLEOTIDE REPEATS;

EID: 84857997415     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.040     Document Type: Article

References (39)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375.
2. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
3. Andre V.M., Cepeda C., Venegas A., Gomez Y., Levine M.S. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. J. Neurophysiol. 2006, 95:2108-2119.
4. Ariano M.A., Cepeda C., Calvert C.R., Flores-Hernandez J., Hernandez-Echeagaray E., Klapstein G.J., Chandler S.H., Aronin N., DiFiglia M., Levine M.S. Striatal potassium channel dysfunction in Huntington's disease transgenic mice. J. Neurophysiol. 2005, 93:2565-2574.
5. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci.: Off. J. Soc. Neurosci. 1999, 19:3248-3257.
6. Cepeda C., Ariano M.A., Calvert C.R., Flores-Hernandez J., Chandler S.H., Leavitt B.R., Hayden M.R., Levine M.S. NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 2001, 66:525-539.
7. Cummings D.M., Milnerwood A.J., Dallerac G.M., Waights V., Brown J.Y., Vatsavayai S.C., Hirst M.C., Murphy K.P. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum. Mol. Genet. 2006, 15:2856-2868.
8. Deransart C., Hellwig B., Heupel-Reuter M., Leger J.F., Heck D., Lucking C.H. Single-unit analysis of substantia nigra pars reticulata neurons in freely behaving rats with genetic absence epilepsy. Epilepsia 2003, 44:1513-1520.
9. Dorner J.L., Miller B.R., Barton S.J., Brock T.J., Rebec G.V. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav. Brain Res. 2007, 178:90-97.
10. Graybiel A.M., Ragsdale C.W. Fiber connections of the basal ganglia. Prog. Brain Res. 1979, 51:237-283.
11. Gu X., Li C., Wei W., Lo V., Gong S., Li S., Iwasato T., Itohara S., Li X.J., Mody L., Heintz N., Yang X.W. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 2005, 46.
12. Gulley J.M., Kosobud A.E., Rebec G.V. Behavior-related modulation of substantia nigra pars reticulata neurons in rats performing a conditioned reinforcement task. Neuroscience 2002, 111:337-349.
13. Hickey M.A., Chesselet M.F. The use of transgenic and knock-in mice to study Huntington's disease. Cytogenet. Genome Res. 2003, 100:276-286.
14. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., Chesselet M.F. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
15. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
16. Jiang H., Stein B.E., McHaffie J.G. Opposing basal ganglia processes shape midbrain visuomotor activity bilaterally. Nature 2003, 423:982-986.
17. Legendy C.R., Salcman M. Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. J. Neurophysiol. 1985, 53:926-939.
18. Levine M.S., Klapstein G.J., Koppel A., Gruen E., Cepeda C., Vargas M.E., Jokel E.S., Carpenter E.M., Zanjani H., Hurst R.S., Efstratiadis A., Zeitlin S., Chesselet M.F. Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 1999, 58:515-532.
19. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
20. Menalled L.B. Knock-in mouse models of Huntington's disease. NeuroRx 2005, 2:465-470.
21. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 2003, 465:11-26.
22. Miller B.R., Walker A.G., Barton S.J., Rebec G.V. Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington's disease. Front. Syst. Neurosci. 2011, 5:26.
23. Miller B.R., Walker A.G., Shah A.S., Barton S.J., Rebec G.V. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J. Neurophysiol. 2008, 100:2205-2216.
24. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 1996, 50:381-425.
25. Murer M.G., Riquelme L.A., Tseng K.Y., Pazo J.H. Substantia nigra pars reticulata single unit activity in normal and 60HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 1997, 27:278-293.
26. Plenz D., Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999, 400:677-682.
27. Rebec G.V., Conroy S.K., Barton S.J. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience 2006, 137:327-336.
28. Richfield E.K., Maguire-Zeiss K.A., Vonkeman H.E., Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann. Neurol. 1995, 38:852-861.
29. Rising A.C., Xu J., Carlson A., Napoli V.V., Denovan-Wright E.M., Mandel R.J. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats. Exp. Neurol. 2011, 228:173-182.
30. Rohlfs A., Nikkhah G., Rosenthal C., Rundfeldt C., Brandis A., Samii M., Loscher W. Hemispheric asymmetries in spontaneous firing characteristics of substantia nigra pars reticulata neurons following a unilateral 6-hydroxydopamine lesion of the rat nigrostriatal pathway. Brain Res. 1997, 761:352-356.
31. Stack E.C., Kubilus J.K., Smith K., Cormier K., Del Signore S.J., Guelin E., Ryu H., Hersch S.M., Ferrante R.J. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol. 2005, 490:354-370.
32. Starr P.A., Kang G.A., Heath S., Shimamoto S., Turner R.S. Pallidal neuronal discharge in Huntington's disease: support for selective loss of striatal cells originating the indirect pathway. Exp, Neurol. 2008, 211:227-233.
33. Tang J.K., Moro E., Lozano A.M., Lang A.E., Hutchison W.D., Mahant N., Dostrovsky J.O. Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients. Exp. Brain Res. Experimentelle Hirnforschung. Experimentation Cerebrale 2005, 166:230-236.
34. Twelvetrees A.E., Yuen E.Y., Arancibia-Carcamo I.L., MacAskill A.F., Rostaing P., Lumb M.J., Humbert S., Triller A., Saudou F., Yan Z., Kittler J.T. Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 2010, 65:53-65.
35. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J Neuropathol. Exp. Neurol. 1985, 44:559-577.
36. Walker A.G., Miller B.R., Fritsch J.N., Barton S.J., Rebec G.V. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J. Neurosci. 2008, 28:8973-8982.
37. Waszczak B.L., Eng N., Walters J.R. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res. 1980, 188:185-197.
38. Windels F., Kiyatkin E.A. GABA not glutamate, controls the activity of substantia nigra reticulata neurons in awake, unrestrained rats. J. Neurosci. 2004, 24:6751-6754.
39. R.C. Wolf, G. Grön, F. Sambataro, N. Vasic, N.D. Wolf, P.A. Thomann, C. Saft, G.B. Landwehrmeyer, M. Orth, Brain activation and functional connectivity in pre- manifest Huntington's disease during states of intrinsic and phasic alertness, Hum. Brain Mapp. (2011), doi:10.1002/hbm.21348.